Bazedoxifene

ADVERTISEMENT

Identification

Molecular formula
C30H34N2O3S
CAS Number
198481-32-2
IUPAC Name
1-[2-[4-[[2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]benzothiophen-3-yl]methyl]phenoxy]ethyl]pyrrolidine
Molecular Weight
470.68g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2800g/cm3
Synonyms
3-[4-(2-pyrrolidin-1-yl-ethoxy)-benzyl]-2-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl] -benzo[b]thiophene
Interesting facts

Exploring 1-[2-[4-[[2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]benzothiophen-3-yl]methyl]phenoxy]ethyl]pyrrolidine

This intriguing compound, commonly referred to as a complex pharmacological agent, showcases the fascinating interplay of structure and function in medicinal chemistry. Known for its multifaceted chemical architecture, it combines the efficacy of pyrrolidine and benzothiophene to create a robust therapeutic candidate.

Key Insights:

  • Diverse Applications: This compound is being studied for its potential use in treating various neurological disorders. Its unique structure allows for interactions with biological pathways that are crucial in drug development.
  • Design Inspiration: The molecule is designed using fragments from different biological scaffolds, making it a prime example of structure-activity relationship (SAR) analysis in drug discovery.
  • Pharmacophore Features: The presence of key functional groups significantly enhances its binding affinity to target receptors, a vital aspect for any therapeutic agent.
  • Synthetic Challenge: The synthesis of such a complex compound poses significant challenges, often requiring advanced techniques in organic synthesis and purification.

The exploration of 1-[2-[4-[[2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]benzothiophen-3-yl]methyl]phenoxy]ethyl]pyrrolidine highlights the continuous advancements in medicinal chemistry and the endless possibilities in designing compounds with specific therapeutic effects. As researchers delve deeper into its properties, we anticipate exciting breakthroughs that could potentially transform treatment paradigms.

ADVERTISEMENT